Nicole Blijlevens
Overview
Explore the profile of Nicole Blijlevens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oudenampsen J, Das E, Blijlevens N, van de Pol M
MedEdPublish (2016)
. 2025 Feb;
13:35.
PMID: 39931185
Background: Interdisciplinary learning is gaining popularity in higher education worldwide. Currently, knowledge about how to appropriately design interdisciplinary education is still lacking. The current study presents the iterative development, pilot,...
2.
Burger D, Nijboer L, Ghobreyal M, Maertens J, Blijlevens N, Hilbrands L, et al.
Clin Pharmacokinet
. 2024 Nov;
63(11):1529-1546.
PMID: 39509076
Letermovir and maribavir have demonstrated efficacy in the prevention and treatment, respectively, of immunosuppressed patients with cytomegalovirus (CMV) infection and disease. These patients often have polypharmacy making them at risk...
3.
Breij D, Hjorth L, Bouwman E, Walraven I, Kepak T, Kepakova K, et al.
Cancer Med
. 2024 Oct;
13(20):e70225.
PMID: 39440690
Background: Childhood cancer survivors face high risks of adverse late health effects. Long-term follow-up care for childhood cancer survivors is crucial to improve their health and quality of life. However,...
4.
Zadik Y, Raber-Durlacher J, Epstein J, Majorana A, Laheij A, Bardellini E, et al.
Support Care Cancer
. 2024 Jul;
32(8):546.
PMID: 39048807
Purpose: A MASCC/ISOO Clinical Practice Statement (CPS) is aimed at generating a concise tool for clinicians, which concentrates practical information needed for the management of oral complications of cancer patients....
5.
Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, et al.
Bone Marrow Transplant
. 2024 Jul;
59(10):1402-1412.
PMID: 38987308
The objective of the study was the analysis of clinical types, outcomes, and risk factors associated with the outcome of adenovirus (ADV) infection, in children and adults after allo-HCT. A...
6.
Abdalla-Aslan R, Bonomo P, Keefe D, Blijlevens N, Cao K, Cheung Y, et al.
EClinicalMedicine
. 2024 Jun;
73:102675.
PMID: 38933098
Background: Mucositis is a common and highly impactful side effect of conventional and emerging cancer therapy and thus the subject of intense investigation. Although common practice, mucositis assessment is heterogeneously...
7.
De Greef J, Averbuch D, Tondeur L, Dureault A, Zuckerman T, Roussel X, et al.
J Infect
. 2024 Apr;
88(6):106162.
PMID: 38663756
Objectives: Nocardiosis is a rare but life-threatening infection after hematopoietic cell transplantation (HCT). We aimed at identifying risk factors for nocardiosis after allogeneic HCT and clarifying the effect of trimethoprim-sulfamethoxazole...
8.
Averbuch D, Tridello G, Wendel L, Itala-Remes M, Oren I, Karas M, et al.
Transplant Cell Ther
. 2024 Apr;
30(7):712.e1-712.e12.
PMID: 38621480
Listeriosis is rare after hematopoietic stem cell transplantation (HCT). Little is known about listeriosis in this population. In this retrospective international case-control study, we evaluated 41 listeriosis episodes occurring between...
9.
Penson A, Walraven I, Bronkhorst E, Grootenhuis M, Maurice-Stam H, van der Heiden-van der Loo M, et al.
Pediatr Blood Cancer
. 2024 Apr;
71(6):e30951.
PMID: 38556733
Introduction: The aim of the current study was to investigate whether subtypes of chronic fatigue (CF) can be identified in childhood cancer survivors (CCS), and if so, to determine the...
10.
Aerts R, Mehra V, Groll A, Martino R, Lagrou K, Robin C, et al.
Lancet Infect Dis
. 2023 Dec;
24(5):e291-e306.
PMID: 38134949
Patients with haematological malignancies might develop life-threatening toxoplasmosis, especially after allogeneic haematopoietic stem-cell transplantation (HSCT). Reactivation of latent cysts is the primary mechanism of toxoplasmosis following HSCT; hence, patients at...